PUNE, India, December 16, 2016 /PRNewswire/ -- The report "Interventional Cardiology & Peripheral Vascular Devices Market (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) - Forecasts to 2021", The global market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1% from 2016 to 2021.
Browse 150 market data Tables and 44 Figures spread through 190 Pages and in-depth TOC on "Interventional Cardiology & Peripheral Vascular Devices Market"
http://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html
Ad Statistics
Times Displayed: 7647
Times Visited: 24 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
Early buyers will receive 10% customization on this report.
This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the interventional cardiology and peripheral vascular devices market, along with revenue estimates & forecasts and market share analysis.
Rising aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are the major factors driving the growth of this market.
On the basis of product, the interventional cardiology and peripheral vascular devices market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. In 2016, the angioplasty stents segment is expected to account for the largest share of the market. High growth in this segment can be attributed to rising number of regulatory approvals, technological advancements, and increasing initiatives by companies for new product launches.
Inquiry before buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=548
On the basis of type, the angioplasty stent market is segmented into drug-eluting stents, bare-metal stents, and bio absorbable stents. In 2016, the drug-eluting stents segment is expected to account for the largest share primarily due to the increasing number of regulatory approvals and technological advancements.
On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the angiography catheters segment is expected to account for the largest share of the market.
On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is expected to account for the largest share primarily due to the rising incidence of smoking and hypertension.
